Zhende Medical (603301) had a net sell of 3.3203 million yuan by main funds on March 27.

According to Securities Star, as of the market close on March 27, 2026, Zhend Medical (603301) closed at 93.98 yuan, up 1.91%, with a turnover rate of 1.92%, a trading volume of 51,000 lots, and a transaction amount of 463 million yuan.

On March 27, the capital flow data indicated that the net outflow of institutional funds was 3.3203 million yuan, accounting for 0.72% of the total transaction amount; the net outflow of retail funds was 4.5135 million yuan, accounting for 0.97% of the total transaction amount; while the net inflow of individual investors was 7.8337 million yuan, accounting for 1.69% of the total transaction amount.

Zhend Medical’s Q3 2025 report shows that in the first three quarters, the company’s main revenue was 3.184 billion yuan, an increase of 1.88% year-on-year; the net profit attributable to shareholders was 203 million yuan, a decrease of 33.91% year-on-year; the net profit excluding non-recurring items was 183 million yuan, a decrease of 18.79% year-on-year; in Q3 2025, the company’s quarterly main revenue was 1.084 billion yuan, an increase of 0.1% year-on-year; the quarterly net profit attributable to shareholders was 75.422 million yuan, a decrease of 48.47% year-on-year; the quarterly net profit excluding non-recurring items was 64.8344 million yuan, an increase of 2.0% year-on-year; the debt ratio was 28.78%, investment income was 8.4885 million yuan, financial expenses were 26.0941 million yuan, and the gross profit margin was 33.93%. Zhend Medical (603301) focuses on the production and sales of basic nursing, surgical infection control, pressure therapy and fixation, ostomy and modern wound care, and infection control protection products.

In the past 90 days, one institution has given a rating for this stock, with one buy rating.

Definition of capital flow: It refers to inferring capital flow through price changes. When the stock price is in an upward trend, the transaction amount formed by proactive buy orders is the force driving the stock price up, and this transaction amount is defined as capital inflow. Conversely, when the stock price is in a downward trend, the transaction amount generated by proactive sell orders is the force driving the stock price down, and this transaction amount is defined as capital outflow. The difference between the two on that day is the net force remaining after the two forces counteract, which pushes the stock price up. The capital flow of institutional funds, retail funds, and individual investors is calculated based on the transaction amount of each individual trade.

Note: Institutional funds refer to large orders, retail funds refer to medium and small orders.

The above content is compiled by Securities Star based on public information and generated by AI algorithms (Cybersecurity Record No. 310104345710301240019), and does not constitute investment advice.